PolyPeptide Group AG is a specialized Contract Development & Manufacturing Organization (CDMO) focused on peptide- and oligonucleotide-based active pharmaceutical ingredients (APIs). It supports pharm... PolyPeptide Group AG is a specialized Contract Development & Manufacturing Organization (CDMO) focused on peptide- and oligonucleotide-based active pharmaceutical ingredients (APIs). It supports pharmaceutical and biotech companies by providing comprehensive services from pre-clinical development through commercial manufacturing, contributing to therapies for millions of patients worldwide, particularly in metabolic diseases like diabetes and obesity via GLP-1 agonists, as well as cancer, cardiovascular, and neurological disorders. Established in 1952 with commercial peptide production beginning in Malmö, Sweden, the company operates a global network of six GMP-certified facilities across Europe, the U.S., and India, ensuring proximity to customers and high-quality delivery. PolyPeptide Group AG manufactures over 1,000 GMP peptides, including proprietary, generic, and cosmetic applications, while advancing into oligonucleotides and sustainable manufacturing processes through innovation and R&D investments. With core values of innovation, excellence, and trust, it maintains a robust pipeline of custom projects, positioning it as a market leader in the fast-growing peptide API sector. Employing around 1,400 people, PolyPeptide Group AG emphasizes long-term partnerships, regulatory compliance, and technological leadership in the pharmaceutical manufacturing landscape.Show lessShow more

Disclosures ESG Data Financial Data

GHG Emissions Climate Targets EU Taxonomy Energy Waste Management

Data not available

PolyPeptide Group is not subject to EU Taxonomy reporting

Based on current regulatory requirements, PolyPeptide Group is not required to report EU Taxonomy data under the CSRD framework. As a result, we have not conducted a detailed EU Taxonomy data review for this company.

If you believe this assessment should be revisited, you may submit a data coverage request and our team will review the company's regulatory applicability.

Would you like us to review PolyPeptide Group's data?

Start your 30-day free trial to request a data review for PolyPeptide Group.

Start Free Trial

Legal Center Contact Us